Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered question first ministerially corrected answering member label attachment file name title previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

155936

registered interest
date	17/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, pursuant to the Answer of 17 November 2014 to Question 214322, what alternative vaccines are available that do not contain porcine gelatine for people who observe religions that restrict the consumption of pork products.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	214790
answer	answer is ministerial correction date of answer 20/11/2014 answer text <p>A number of vaccines contain porcine gelatine, which is used to stabilise live viral vaccines and is contained in many pharmaceutical products. The vaccines used in the national immunisation programme which contain porcine gelatine are Fluenz®, measles, mumps and rubella (MMR) VaxPro® and Zostavax®.</p><p> </p><p> </p><p> </p><p>Fluenz® is used to immunise children against flu. It is a live attenuated vaccine which is administered by means of a nasal spray. There is no equivalent appropriate alternative which offers the same degree of protection, nor is there any other live attenuated vaccine available in Europe.</p><p> </p><p> </p><p> </p><p>MMR VaxPro® is used to immunise against MMR. There is an alternative vaccine, Priorix®, which does not contain porcine gelatine and offers equivalent protection.</p><p> </p><p> </p><p> </p><p>Zostavax® is used to immunise adults against shingles. There is no alternative vaccine licensed for use in the United Kingdom.</p><p> </p><p><strong> </strong></p><p> </p><p>Public Health England (PHE) has gained broad acceptance from faith groups for the use of porcine gelatine in non-oral medicines and more information can be found at PHE’s website:</p><p> </p><p> </p><p> </p><p><a href="http://www.gov.uk/government/news/vaccines-and-gelatine-phe-response" target="_blank">www.gov.uk/government/news/vaccines-and-gelatine-phe-response</a></p><p> </p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 20/11/2014 14:34:30 answering member 3918 label Biography information for Jane Ellison
tabling member	4036 label Biography information for Luciana Berger

101287

registered interest
date	28/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Vaccination
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government whether they are reassessing the United Kingdom's capability in vaccine development and production with a view to reducing the time taken to produce new vaccines for use against emerging diseases.
tabling member printed	Lord Moonie
uin	HL2492
answer	answer is ministerial correction date of answer 11/11/2014 answer text <p>We are not currently reassessing the United Kingdom’s capability in vaccine development and production, which is primarily a matter for the pharmaceutical industry.</p><p> </p><p> </p><p> </p><p>However, our horizon-scanning and surveillance for emerging infectious diseases and the development of arrangements for emergency preparedness and response will include collaboration with the pharmaceutical industry when the use of a vaccine may be a potential control measure.</p><p> </p><p> </p><p> </p><p>One example of this work is the current efforts to accelerate clinical trials for an Ebola vaccine, working closely with other Governments, vaccine regulators, industry and the World Health Organization.</p><p> </p> answering member printed Earl Howe question first answered 11/11/2014 12:02:12 answering member 2000 label Biography information for Earl Howe
tabling member	621 label Biography information for Lord Moonie

90113

registered interest
date	01/09/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what the outcomes were of each routine immunisation programme over the last 10 years; what steps he is taking to encourage greater levels of coverage over the next 10 years; and if he will make a statement.
tabling member constituency	Reigate
tabling member printed	Crispin Blunt
uin	207575
answer	answer is ministerial correction date of answer 08/09/2014 answer text <p> </p><p>The Department and NHS England, advised by Public Health England, have produced a series of service specifications for the commissioning of immunisation services. These generally state that local services must ensure that they maintain and improve immunisation uptake with the aspiration of 100% of relevant individuals being offered immunisation.</p><p> </p><p> </p><p> </p><p>The local Directors’ of Public Health have responsibility for providing appropriate challenge to local immunisation arrangements and advocacy with key stakeholders to ensure access to vaccinations improved uptake by eligible populations.</p><p> </p><p> </p><p> </p><p>Coverage for most routine universal childhood immunisation programmes has improved over the last decade and is now approaching or above 95% in most English regions and continues to increase at a national level. Vaccine uptake in the UK is among the highest in the world. Annual immunisation coverage statistics are published by the Health and Social Care Information Centre and a copy of the most recent report for 2012-13 has been placed in the Library.</p><p> </p><p> </p><p> </p><p>Public Health England monitors vaccine coverage levels and works jointly with the NHS to encourage increased vaccination uptake, including through promoting vaccination to parents and carers through advertising and media campaigns.</p><p> </p><p> </p><p> </p><p>Public Health England defines outbreaks according to the World Health Organisation’s definition, which is that <em>‘A disease outbreak is the occurrence of cases of disease in excess of what would normally be expected in a defined community, geographical area or season’.</em></p><p> </p><p>Cases of vaccine preventable disease are at historically low levels and in the last 10 years, national outbreaks have only been observed for three vaccine preventable diseases – mumps, pertussis and measles.</p><p> </p><p> </p><p>During the early years of the century, for example, vaccine coverage of measles, mumps and rubella (MMR) fell following the unfounded concerns about vaccine safety. In 2008, the Chief Medical Officer announced a national catch-up campaign to offer MMR to any individuals under 18 years of age to ensure they were fully protected. In April 2013, a national MMR catch up campaign in those aged 10 to 16 years was launched in England.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 207576 question first answered 08/09/2014 14:49:09 answering member 3918 label Biography information for Jane Ellison attachment 1 file name PQ207576 - Lib Doc - Report.pdf title Report
tabling member	104 label Biography information for Crispin Blunt

90116

registered interest
date	01/09/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what roles (a) his Department, (b) Public Health England, (c) NHS England, (d) immunisation providers, (e) clinical commissioning groups and (f) local authorities have in the delivery of immunisation services.
tabling member constituency	Reigate
tabling member printed	Crispin Blunt
uin	207577
answer	answer is ministerial correction date of answer 08/09/2014 answer text <p> </p><p>Public Health England and NHS England have published the <em>Immunisation &amp; Screening National Delivery Framework &amp; Local Operating Model</em>. This document sets out the immunisation roles and responsibilities of respective agencies involved, and how national, regional, and local operational and governance arrangements for national immunisation programmes in England are coordinated. A copy has been placed in the Library.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 08/09/2014 15:25:42 answering member 3918 label Biography information for Jane Ellison attachment 1 file name PQ207577 - Lib Doc - Report.pdf title Library Document
tabling member	104 label Biography information for Crispin Blunt

90121

registered interest
date	01/09/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, on what occasions over the last 10 years steps have needed to be taken to increase levels of coverage of vaccinations because coverage has fallen to significantly low levels; what outbreaks of vaccine-preventable disease there have been in the UK in the last 10 years; what his definition of an outbreak is for this purpose; and if he will make a statement.
tabling member constituency	Reigate
tabling member printed	Crispin Blunt
uin	207576
answer	answer is ministerial correction date of answer 08/09/2014 answer text <p> </p><p>The Department and NHS England, advised by Public Health England, have produced a series of service specifications for the commissioning of immunisation services. These generally state that local services must ensure that they maintain and improve immunisation uptake with the aspiration of 100% of relevant individuals being offered immunisation.</p><p> </p><p> </p><p> </p><p>The local Directors’ of Public Health have responsibility for providing appropriate challenge to local immunisation arrangements and advocacy with key stakeholders to ensure access to vaccinations improved uptake by eligible populations.</p><p> </p><p> </p><p> </p><p>Coverage for most routine universal childhood immunisation programmes has improved over the last decade and is now approaching or above 95% in most English regions and continues to increase at a national level. Vaccine uptake in the UK is among the highest in the world. Annual immunisation coverage statistics are published by the Health and Social Care Information Centre and a copy of the most recent report for 2012-13 has been placed in the Library.</p><p> </p><p> </p><p> </p><p>Public Health England monitors vaccine coverage levels and works jointly with the NHS to encourage increased vaccination uptake, including through promoting vaccination to parents and carers through advertising and media campaigns.</p><p> </p><p> </p><p> </p><p>Public Health England defines outbreaks according to the World Health Organisation’s definition, which is that <em>‘A disease outbreak is the occurrence of cases of disease in excess of what would normally be expected in a defined community, geographical area or season’.</em></p><p> </p><p>Cases of vaccine preventable disease are at historically low levels and in the last 10 years, national outbreaks have only been observed for three vaccine preventable diseases – mumps, pertussis and measles.</p><p> </p><p> </p><p>During the early years of the century, for example, vaccine coverage of measles, mumps and rubella (MMR) fell following the unfounded concerns about vaccine safety. In 2008, the Chief Medical Officer announced a national catch-up campaign to offer MMR to any individuals under 18 years of age to ensure they were fully protected. In April 2013, a national MMR catch up campaign in those aged 10 to 16 years was launched in England.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 207575 question first answered 08/09/2014 14:49:13 answering member 3918 label Biography information for Jane Ellison attachment 1 file name PQ207576 - Lib Doc - Report.pdf title Report
tabling member	104 label Biography information for Crispin Blunt

90125

registered interest
date	01/09/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what payments have been received in the 2014-15 financial year by GPs for the delivery of vaccines through each routine immunisation programme, broken down by (a) item-of-service payment, (b) administration fee, (c) reimbursement cost, (d) Quality and Outcomes Framework reward and (e) Directed Enhanced Service payment; and if he will make a statement.
tabling member constituency	Reigate
tabling member printed	Crispin Blunt
uin	207552
answer	answer is ministerial correction date of answer 08/09/2014 answer text <p>Data for the current financial year <ins class="ministerial">are </ins><del class="ministerial"> is</del> not yet available. Financial data on overall spend of vaccination and immunisation programmes <ins class="ministerial">in general practice are </ins><del class="ministerial">is</del> published by the Health and Social Care Information Centre (HSCIC) <del class="ministerial">once it has undergone routine checks and audits as set by the National Audit Office</del>.</p><p> </p><p> </p><p> </p><p>HSCIC <del class="ministerial">will</del> publish<ins class="ministerial">ed</ins> the data for 2013-14 on <ins class="ministerial">19 </ins><del class="ministerial">22</del> September 2014.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 08/09/2014 14:40:24 question first ministerially corrected 28/10/2014 11:10:30 answering member 3918 label Biography information for Jane Ellison previous answer version 18802 answering member constituency Battersea answering member printed Jane Ellison answering member 3918 label Biography information for Jane Ellison
tabling member	104 label Biography information for Crispin Blunt

90127

registered interest
date	01/09/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what plans the National Institute for Health and Care Excellence has to update its guideline on reducing differences in the uptake of immunisation, published in September 2009; whether the guideline will be extended to include uptake in people over the age of 18 years; and if he will make a statement.
tabling member constituency	Reigate
tabling member printed	Crispin Blunt
uin	207557
answer	answer is ministerial correction date of answer 08/09/2014 answer text <p> </p><p>The National Institute for Health and Care Excellence (NICE) is an independent body and is responsible for the review of its existing guidance.</p><p> </p><p> </p><p> </p><p>NICE published public health guidance on <em>Reducing differences in the uptake of immunisations</em> in 2009 and reviewed the need to update the guidance in consultation with stakeholders in late 2012. NICE announced in February 2013 its conclusion that the guidance did not need to be updated at that time.</p><p> </p><p> </p><p> </p><p>I understand that NICE intends to review again the need to update the guidance in 2015. Further information will be made available at:</p><p> </p><p> </p><p>www.nice.org.uk/Guidance/PH21</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 08/09/2014 15:08:24 answering member 3918 label Biography information for Jane Ellison
tabling member	104 label Biography information for Crispin Blunt

90128

registered interest
date	01/09/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how community pharmacies are paid for the delivery of immunisation services in each area of the UK where NHS England commissions them to do so.
tabling member constituency	Reigate
tabling member printed	Crispin Blunt
uin	207587
answer	answer is ministerial correction date of answer 11/09/2014 answer text <p> </p><p>Information is not held centrally by NHS England on immunisation services commissioned locally from community pharmacists.</p><p> </p><p> </p><p> </p><p>NHS England has advised that such immunisation services are commissioned by NHS England, through service level agreements, as local enhanced services within the community pharmacy contractual framework. As this type of service is commissioned according to local need, actual payments will vary.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 207586 question first answered 11/09/2014 14:04:34 answering member 4020 label Biography information for George Freeman
tabling member	104 label Biography information for Crispin Blunt

90129

registered interest
date	01/09/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what immunisation programmes were offered by the NHS in the (a) 2013-14, (b) 2012-13 and (c) 2011-12 financial year; to whom each vaccine was offered; what the size was of the eligible patient population for each immunisation; and what the uptake rate was (i) in England and (ii) in each NHS England area team.
tabling member constituency	Reigate
tabling member printed	Crispin Blunt
uin	207559
answer	answer is ministerial correction date of answer 08/09/2014 answer text <p> </p><p>Information relating to National Health Service immunisation programmes offered is not available by financial year. However, the immunisation programmes offered by the NHS since September 2012 can be found in the following documents, copies of which have been placed in the Library:</p><p> </p><p> </p><p> </p><p><em>The complete routine immunisation schedule from summer 2014</em></p><p> </p><p><em>The complete routine immunisation schedule 2013/14</em></p><p> </p><p><em>The routine childhood immunisation schedule (September 2012)</em></p><p> </p><p> </p><p> </p><p>Detailed information about the routine immunisation schedule and other recommended vaccines, which are not offered routinely, is contained in the document <em>Immunisation against Infectious Diseases</em> . This is a live scientific document which is constantly updated and can be seen at:</p><p> </p><p> </p><p> </p><p>www.gov.uk/government/collections/immunisation-against-infectious-disease-the-green-book</p><p> </p><p> </p><p> </p><p>The Health and Social Care Information Centre publishes an annual report entitled <em>NHS Immunisation Statistics</em> which provides data on uptake of routine childhood immunisations, targeted routine childhood immunisations and seasonal influenza immunisation for those aged 65 years or over. Copies of the reports for 2011-12 and 2012-13 have been placed in the Library. The report for 2013-14 will be published later this month.</p><p> </p><p> </p><p> </p><p>Public Health England and the Health Protection Agency have published data on the uptake of immunisation against seasonal influenza and human papillomavirus disease. Copies of available reports for 2011-12, 2012-13 and 2013-2014 have been placed in the Library.</p><p> </p><p> </p><p> </p><p>The timeline for the introduction of vaccination programmes in this country is available in the publication <em>Historical vaccine development and introduction of vaccines in the UK</em>, a copy of which has been placed in the Library.</p><p> </p><p> </p><p> </p><p>Detailed information on which provider administers vaccine is not collected nationally. The vast majority of immunisation programmes are delivered in general practice. The teenage HPV immunisation programme is largely delivered by school health services and childhood flu immunisation of school aged children will largely take place in schools.</p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 207579 207583 207643 question first answered 08/09/2014 16:21:14 answering member 3918 label Biography information for Jane Ellison
tabling member	104 label Biography information for Crispin Blunt

90130

registered interest
date	01/09/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, in which areas NHS England commissioned immunisation services from community pharmacies in the 2013-14 financial year; what estimate he has made of the number of community pharmacies which were commissioned to deliver immunisation services in each area; what estimate he has made of the number of doses of vaccine which were delivered though community pharmacies in the 2013-14 financial year in each area; and if he will make a statement.
tabling member constituency	Reigate
tabling member printed	Crispin Blunt
uin	207586
answer	answer is ministerial correction date of answer 11/09/2014 answer text <p> </p><p>Information is not held centrally by NHS England on immunisation services commissioned locally from community pharmacists.</p><p> </p><p> </p><p> </p><p>NHS England has advised that such immunisation services are commissioned by NHS England, through service level agreements, as local enhanced services within the community pharmacy contractual framework. As this type of service is commissioned according to local need, actual payments will vary.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 207587 question first answered 11/09/2014 14:04:34 answering member 4020 label Biography information for George Freeman
tabling member	104 label Biography information for Crispin Blunt